Poster Session C - Monday Afternoon
Category: IBD
Sanket D. Basida, MD
University of Missouri
Columbia, MO
| ||||
Variables | Crohn’s with no SBS* (Control) | Crohn’s with SBS* (Study) | p-value | |
Hospital acquired pneumonia | 0.78% | 3.36% | < 0.001 | |
Adjusted odds ratio1=2.93 | 0.042 | |||
Catheter related blood-stream infection | 0.1% | 1.68% | < 0.001 | |
Adjusted odds ratio1=7.71 | 0.005 | |||
Sepsis | 1.19%% | 5.88% | < 0.001 | |
Adjusted odds ratio1=2.99 | 0.006 | |||
Septic shock | 0.51% | 2.52% | 0.002 | |
Adjusted odds ratio1 = 2.36 | 0.15 | |||
Hyponatremia | 6.07% | 16.81% | < 0.001 | |
Adjusted odds ratio1=1.79 | 0.02 | |||
Venous thrombo-embolism | 0.77% | 2.52% | 0.02 | |
Adjusted odds ratio1=1.84 | 0.29 | |||
Iron deficiency anemia | 12.49% | 31.09% | < 0.001 | |
Adjusted odds ratio1=1.68 | 0.045 | |||
Mean total hospitalization charge ($) | $44,911 | $100,203 | < 0.001 | |
Mean change in charges1 = $44,359 | < 0.001 | |||
Mean length of stay (days) | 4.78 | 12.53 | < 0.001 | |
Mean change in length of stay1 = 6.35 | < 0.001 | |||
In-hospital mortality | 0.2% | 0.84% | 0.11 | |
Adjusted odds ratio1=2.44 | 0.39 |